Click for best price
Novel Drug Delivery Systems Market Size, Share 2023
| Market size in 2022 |
US$ 25000 million
|
Forecast Market size by 2029 |
US$ 27990 million
|
| Growth Rate |
CAGR of 1.6% |
Number of Pages |
112 Pages |
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
This report aims to provide a comprehensive presentation of the global market for Novel Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Delivery Systems. This report contains market size and forecasts of Novel Drug Delivery Systems in global, including the following market information:
Global Novel Drug Delivery Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Novel Drug Delivery Systems market was valued at US$ 25000 million in 2022 and is projected to reach US$ 27990 million by 2029, at a CAGR of 1.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
We surveyed the Novel Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Drug Delivery Systems Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Novel Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein?drug Conjugates
Others
Global Novel Drug Delivery Systems Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Novel Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)
Hospitals & Clinic
Cancer Treatment Centers
Others
Global Novel Drug Delivery Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Novel Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Drug Delivery Systems revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Novel Drug Delivery Systems revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
AMAG Pharmaceuticals
AbbVie
Dr Reddy
AstraZeneca
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Novel Drug Delivery Systems, market overview.
Chapter 2: Global Novel Drug Delivery Systems market size in revenue.
Chapter 3: Detailed analysis of Novel Drug Delivery Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Novel Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Novel Drug Delivery Systems Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 25000 million
|
| Forecast Market size by 2029 |
US$ 27990 million
|
| Growth Rate |
CAGR of 1.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Novel Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Novel Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Novel Drug Delivery Systems Overall Market Size
2.1 Global Novel Drug Delivery Systems Market Size: 2022 VS 2029
2.2 Global Novel Drug Delivery Systems Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Novel Drug Delivery Systems Players in Global Market
3.2 Top Global Novel Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Novel Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Novel Drug Delivery Systems Companies in Global Market, by Revenue in 2022
3.5 Global Companies Novel Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Novel Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Novel Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Novel Drug Delivery Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Novel Drug Delivery Systems Market Size Markets, 2022 & 2029
4.1.2 Liposomes
4.1.3 PEGylated Proteins & Polypeptides
4.1.4 Polymer Nanoparticle
4.1.5 Protein?drug Conjugates
4.1.6 Others
4.2 By Type - Global Novel Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Novel Drug Delivery Systems Revenue, 2018-2023
4.2.2 By Type - Global Novel Drug Delivery Systems Revenue, 2024-2029
4.2.3 By Type - Global Novel Drug Delivery Systems Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Novel Drug Delivery Systems Market Size, 2022 & 2029
5.1.2 Hospitals & Clinic
5.1.3 Cancer Treatment Centers
5.1.4 Others
5.2 By Application - Global Novel Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Novel Drug Delivery Systems Revenue, 2018-2023
5.2.2 By Application - Global Novel Drug Delivery Systems Revenue, 2024-2029
5.2.3 By Application - Global Novel Drug Delivery Systems Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Novel Drug Delivery Systems Market Size, 2022 & 2029
6.2 By Region - Global Novel Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Novel Drug Delivery Systems Revenue, 2018-2023
6.2.2 By Region - Global Novel Drug Delivery Systems Revenue, 2024-2029
6.2.3 By Region - Global Novel Drug Delivery Systems Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Novel Drug Delivery Systems Revenue, 2018-2029
6.3.2 US Novel Drug Delivery Systems Market Size, 2018-2029
6.3.3 Canada Novel Drug Delivery Systems Market Size, 2018-2029
6.3.4 Mexico Novel Drug Delivery Systems Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Novel Drug Delivery Systems Revenue, 2018-2029
6.4.2 Germany Novel Drug Delivery Systems Market Size, 2018-2029
6.4.3 France Novel Drug Delivery Systems Market Size, 2018-2029
6.4.4 U.K. Novel Drug Delivery Systems Market Size, 2018-2029
6.4.5 Italy Novel Drug Delivery Systems Market Size, 2018-2029
6.4.6 Russia Novel Drug Delivery Systems Market Size, 2018-2029
6.4.7 Nordic Countries Novel Drug Delivery Systems Market Size, 2018-2029
6.4.8 Benelux Novel Drug Delivery Systems Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Novel Drug Delivery Systems Revenue, 2018-2029
6.5.2 China Novel Drug Delivery Systems Market Size, 2018-2029
6.5.3 Japan Novel Drug Delivery Systems Market Size, 2018-2029
6.5.4 South Korea Novel Drug Delivery Systems Market Size, 2018-2029
6.5.5 Southeast Asia Novel Drug Delivery Systems Market Size, 2018-2029
6.5.6 India Novel Drug Delivery Systems Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Novel Drug Delivery Systems Revenue, 2018-2029
6.6.2 Brazil Novel Drug Delivery Systems Market Size, 2018-2029
6.6.3 Argentina Novel Drug Delivery Systems Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Novel Drug Delivery Systems Revenue, 2018-2029
6.7.2 Turkey Novel Drug Delivery Systems Market Size, 2018-2029
6.7.3 Israel Novel Drug Delivery Systems Market Size, 2018-2029
6.7.4 Saudi Arabia Novel Drug Delivery Systems Market Size, 2018-2029
6.7.5 UAE Novel Drug Delivery Systems Market Size, 2018-2029
7 Novel Drug Delivery Systems Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Novel Drug Delivery Systems Major Product Offerings
7.1.4 Amgen Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Novel Drug Delivery Systems Major Product Offerings
7.2.4 Teva Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Novel Drug Delivery Systems Major Product Offerings
7.3.4 Roche Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 UCB (Union Chimique Belge)
7.4.1 UCB (Union Chimique Belge) Company Summary
7.4.2 UCB (Union Chimique Belge) Business Overview
7.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Major Product Offerings
7.4.4 UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.4.5 UCB (Union Chimique Belge) Key News & Latest Developments
7.5 Celgene
7.5.1 Celgene Company Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Novel Drug Delivery Systems Major Product Offerings
7.5.4 Celgene Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.5.5 Celgene Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Novel Drug Delivery Systems Major Product Offerings
7.6.4 Merck Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Gilead Sciences
7.7.1 Gilead Sciences Company Summary
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Novel Drug Delivery Systems Major Product Offerings
7.7.4 Gilead Sciences Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.7.5 Gilead Sciences Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Novel Drug Delivery Systems Major Product Offerings
7.8.4 Sanofi Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Novel Drug Delivery Systems Major Product Offerings
7.9.4 Pfizer Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Takeda
7.10.1 Takeda Company Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Novel Drug Delivery Systems Major Product Offerings
7.10.4 Takeda Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.10.5 Takeda Key News & Latest Developments
7.11 Bausch&Lomb
7.11.1 Bausch&Lomb Company Summary
7.11.2 Bausch&Lomb Business Overview
7.11.3 Bausch&Lomb Novel Drug Delivery Systems Major Product Offerings
7.11.4 Bausch&Lomb Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.11.5 Bausch&Lomb Key News & Latest Developments
7.12 Samyang Biopharmaceuticals
7.12.1 Samyang Biopharmaceuticals Company Summary
7.12.2 Samyang Biopharmaceuticals Business Overview
7.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Major Product Offerings
7.12.4 Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.12.5 Samyang Biopharmaceuticals Key News & Latest Developments
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Company Summary
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Novel Drug Delivery Systems Major Product Offerings
7.13.4 Johnson & Johnson Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.13.5 Johnson & Johnson Key News & Latest Developments
7.14 TOLMAR
7.14.1 TOLMAR Company Summary
7.14.2 TOLMAR Business Overview
7.14.3 TOLMAR Novel Drug Delivery Systems Major Product Offerings
7.14.4 TOLMAR Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.14.5 TOLMAR Key News & Latest Developments
7.15 Astellas
7.15.1 Astellas Company Summary
7.15.2 Astellas Business Overview
7.15.3 Astellas Novel Drug Delivery Systems Major Product Offerings
7.15.4 Astellas Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.15.5 Astellas Key News & Latest Developments
7.16 AMAG Pharmaceuticals
7.16.1 AMAG Pharmaceuticals Company Summary
7.16.2 AMAG Pharmaceuticals Business Overview
7.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Major Product Offerings
7.16.4 AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.16.5 AMAG Pharmaceuticals Key News & Latest Developments
7.17 AbbVie
7.17.1 AbbVie Company Summary
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Novel Drug Delivery Systems Major Product Offerings
7.17.4 AbbVie Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.17.5 AbbVie Key News & Latest Developments
7.18 Dr Reddy
7.18.1 Dr Reddy Company Summary
7.18.2 Dr Reddy Business Overview
7.18.3 Dr Reddy Novel Drug Delivery Systems Major Product Offerings
7.18.4 Dr Reddy Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.18.5 Dr Reddy Key News & Latest Developments
7.19 AstraZeneca
7.19.1 AstraZeneca Company Summary
7.19.2 AstraZeneca Business Overview
7.19.3 AstraZeneca Novel Drug Delivery Systems Major Product Offerings
7.19.4 AstraZeneca Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.19.5 AstraZeneca Key News & Latest Developments
7.20 Aspen
7.20.1 Aspen Company Summary
7.20.2 Aspen Business Overview
7.20.3 Aspen Novel Drug Delivery Systems Major Product Offerings
7.20.4 Aspen Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.20.5 Aspen Key News & Latest Developments
7.21 Acrotech Biopharma
7.21.1 Acrotech Biopharma Company Summary
7.21.2 Acrotech Biopharma Business Overview
7.21.3 Acrotech Biopharma Novel Drug Delivery Systems Major Product Offerings
7.21.4 Acrotech Biopharma Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.21.5 Acrotech Biopharma Key News & Latest Developments
7.22 TWi Pharmaceuticals
7.22.1 TWi Pharmaceuticals Company Summary
7.22.2 TWi Pharmaceuticals Business Overview
7.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Major Product Offerings
7.22.4 TWi Pharmaceuticals Novel Drug Delivery Systems Revenue in Global Market (2018-2023)
7.22.5 TWi Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Novel Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Novel Drug Delivery Systems Market Drivers in Global Market
Table 3. Novel Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Novel Drug Delivery Systems in Global Market
Table 5. Top Novel Drug Delivery Systems Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Novel Drug Delivery Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Novel Drug Delivery Systems Revenue Share by Companies, 2018-2023
Table 8. Global Companies Novel Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Novel Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Novel Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Novel Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Novel Drug Delivery Systems Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Novel Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Novel Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Novel Drug Delivery Systems Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Novel Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Novel Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Novel Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Novel Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Novel Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Novel Drug Delivery Systems Product Offerings
Table 32. Amgen Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Teva Company Summary
Table 35. Teva Novel Drug Delivery Systems Product Offerings
Table 36. Teva Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Novel Drug Delivery Systems Product Offerings
Table 40. Roche Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. UCB (Union Chimique Belge) Company Summary
Table 43. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Offerings
Table 44. UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 45. UCB (Union Chimique Belge) Key News & Latest Developments
Table 46. Celgene Company Summary
Table 47. Celgene Novel Drug Delivery Systems Product Offerings
Table 48. Celgene Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Novel Drug Delivery Systems Product Offerings
Table 52. Merck Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Gilead Sciences Company Summary
Table 55. Gilead Sciences Novel Drug Delivery Systems Product Offerings
Table 56. Gilead Sciences Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 57. Gilead Sciences Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Novel Drug Delivery Systems Product Offerings
Table 60. Sanofi Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Novel Drug Delivery Systems Product Offerings
Table 64. Pfizer Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Takeda Company Summary
Table 67. Takeda Novel Drug Delivery Systems Product Offerings
Table 68. Takeda Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 69. Takeda Key News & Latest Developments
Table 70. Bausch&Lomb Company Summary
Table 71. Bausch&Lomb Novel Drug Delivery Systems Product Offerings
Table 72. Bausch&Lomb Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 73. Bausch&Lomb Key News & Latest Developments
Table 74. Samyang Biopharmaceuticals Company Summary
Table 75. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Offerings
Table 76. Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 77. Samyang Biopharmaceuticals Key News & Latest Developments
Table 78. Johnson & Johnson Company Summary
Table 79. Johnson & Johnson Novel Drug Delivery Systems Product Offerings
Table 80. Johnson & Johnson Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 81. Johnson & Johnson Key News & Latest Developments
Table 82. TOLMAR Company Summary
Table 83. TOLMAR Novel Drug Delivery Systems Product Offerings
Table 84. TOLMAR Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 85. TOLMAR Key News & Latest Developments
Table 86. Astellas Company Summary
Table 87. Astellas Novel Drug Delivery Systems Product Offerings
Table 88. Astellas Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 89. Astellas Key News & Latest Developments
Table 90. AMAG Pharmaceuticals Company Summary
Table 91. AMAG Pharmaceuticals Novel Drug Delivery Systems Product Offerings
Table 92. AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 93. AMAG Pharmaceuticals Key News & Latest Developments
Table 94. AbbVie Company Summary
Table 95. AbbVie Novel Drug Delivery Systems Product Offerings
Table 96. AbbVie Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 97. AbbVie Key News & Latest Developments
Table 98. Dr Reddy Company Summary
Table 99. Dr Reddy Novel Drug Delivery Systems Product Offerings
Table 100. Dr Reddy Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 101. Dr Reddy Key News & Latest Developments
Table 102. AstraZeneca Company Summary
Table 103. AstraZeneca Novel Drug Delivery Systems Product Offerings
Table 104. AstraZeneca Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 105. AstraZeneca Key News & Latest Developments
Table 106. Aspen Company Summary
Table 107. Aspen Novel Drug Delivery Systems Product Offerings
Table 108. Aspen Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 109. Aspen Key News & Latest Developments
Table 110. Acrotech Biopharma Company Summary
Table 111. Acrotech Biopharma Novel Drug Delivery Systems Product Offerings
Table 112. Acrotech Biopharma Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 113. Acrotech Biopharma Key News & Latest Developments
Table 114. TWi Pharmaceuticals Company Summary
Table 115. TWi Pharmaceuticals Novel Drug Delivery Systems Product Offerings
Table 116. TWi Pharmaceuticals Novel Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 117. TWi Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Novel Drug Delivery Systems Segment by Type in 2022
Figure 2. Novel Drug Delivery Systems Segment by Application in 2022
Figure 3. Global Novel Drug Delivery Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Novel Drug Delivery Systems Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Novel Drug Delivery Systems Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Novel Drug Delivery Systems Revenue in 2022
Figure 8. By Type - Global Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 9. By Application - Global Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 10. By Type - Global Novel Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 12. By Application - Global Novel Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 14. By Region - Global Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 15. By Country - North America Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 16. US Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 20. Germany Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 21. France Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 28. China Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 32. India Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 34. Brazil Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Novel Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 37. Turkey Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Novel Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Gilead Sciences Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takeda Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bausch&Lomb Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Samyang Biopharmaceuticals Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Johnson & Johnson Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. TOLMAR Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Astellas Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. AMAG Pharmaceuticals Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. AbbVie Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Dr Reddy Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. AstraZeneca Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Aspen Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Acrotech Biopharma Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. TWi Pharmaceuticals Novel Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
